Home Search
welsh - search results
If you're not happy with the results, please do another search
Welsh Carson among winners in latest CalPERS commitments
The California Public Employees' Retirement System has committed $400m to Welsh, Carson, Anderson & Stowe XIII.
WCAS company makes offer for Abzena, values at £34.4m
Astro Bidco – a Welsh Carson, Anderson & Stowe portfolio business – has made an offer for biopharmaceutical services company Abzena, valuing it at £34.4m.
UPDATE: Welsh, Carson, Anderson & Stowe strikes $2.8bn first close for Fund XIII
New-York buyout house Welsh, Carson, Anderson & Stowe has raised over $2.8bn for the first close of its latest flagship fund and related vehicles, AltAssets can reveal.
New State Capital staffs up following oversubscribed $255m Fund II close
New State Capital Partners has followed the recent $255m final close of its second fund by bringing in four new executives.
TPG, Welsh Carson team with Humana Inc for $1.4bn Curo Health Services buyout
TPG Capital and Welsh, Carson, Anderson & Stowe have teamed up with NYSE-listed Humana Inc to buy hospice operator Curo Health Services for about $1.4bn.
WCAS snaps up majority stake in cloud-based compliance business Avetta
Welsh, Carson, Anderson & Stowe (WCAS) has acquired a majority stake in Avetta, a cloud-based supply chain risk management business.
PE records biggest dealmaking value total for a decade in 2017 despite continued volume...
Overall private equity dealmaking value rebounded to a ten-year high across 2017 despite volume sliding for the second consecutive year, new research reveals.
Welsh Carson brings on board experienced FFL fundraising, IR head Lau
US buyout major Welsh Carson Anderson & Stowe has boosted its investor relations team by bringing in FFL Partners head of fundraising and IR Gregory Lau.
Welsh Carson to finally exit 2004 investment Aptuit through $300m Evotec sale
Welsh Carson Anderson and Stowe has finally agreed to exit its 13-year investment in drug development services business Aptuit through a $300m sale to trade buyer Evotec.
Hooper returns to Welsh Carson to boost firm’s Bay Area push
Christopher Hooper has rejoined tech and healthcare-targeting private equity firm Welsh Carson Anderson & Stowe as a general partner after six years at Golden Gate Capital.
Popular Articles
Carlyle’s AlpInvest arm passes $6.5bn for latest secondaries raise, has begun investing fund
AlpInvest, Carlyle’s secondaries and fund of funds investment arm, is around halfway to its goal for its latest flagship fund after picking up more than $6.5bn.
Deal Roundup: Sycamore among PE firms eyeing Nordstrom, Bain Capital said to seek Atos...
Sycamore Partners is reportedly among private equity bidders for listed US department store Nordstrom. Sycamore, which already owns US department store operator Belk, is...
HighVista eyes “unusually compelling” small buyout opportunity with new $675m fund
Boston-based private and public investor HighVista Strategies has hit a $675m final close for its tenth flagship PE fund.
Latticework Capital more than doubles AUM with $345m sophomore healthcare fund close
Healthcare-focused private equity house Latticework Capital Management has hit a $345m final close for its second fund, beating its initial target.
Latin American banking major BTG Pactual completes $1bn-plus Strategic Capital fundraise
Latin American investment bank BTG Pactual has raised more than $1bn for its opportunistic asset-focused fund strategy.
Impressive exits help Hyde Park Venture Partners picks up $98m for new US Midwest,...
Early stage tech investor Hyde Park Venture Partners has raised $98m for its fourth flagship venture capital fund, a whisker shy of the $100m collected for its predecessor fund.
Capman strikes €130m hard cap for its biggest growth fund to date
Nordic private equity investor CapMan has hit its €130m hard cap for its third growth equity fund, a 34% size increase compared to its predecessor vehicle.
Deal Roundup: BioCatch gets $1.3bn valuation through Permira investment, BGF scores big exit
Permira has agreed to buy a majority stake in digital fraud detection business BioCatch, valuing the company at about $1.3bn. Existing backers Sapphire Ventures...
Venture capital fundraising remains weak amid under-performing distributions
Lower than expected distributions are weighing on the venture capital fundraising market, with LPs being returned less cash from their VC commitments to re-invest in new vehicles.
Deal Roundup: Roark completes $9.6bn Subway buy, TA buys into LLR’s Edmunds GovTech
Sandwich restaruant giant Subway has completed its $9.6bn sale to Roark Capital. The company said the sale followed three years of sales growth and...
